Open Public Hearing

1
Open Public Hearing

• Congresswoman Donna M. Christensen, M.D.
• Chair, Congressional Black Caucus CBC

Cardiovascular and Renal Drugs Advisory
Committee June 16, 2005
2
Open Public Hearing

• Gary A. Puckrein, Ph.D.
• National Minority Health Month Foundation

Cardiovascular and Renal Drugs Advisory
Committee June 16, 2005
3
Open Public Hearing

• 3. B. Waine Kong, J.D., Ph.D.
• CEO American Association of Black
  Cardiologists ABC

Cardiovascular and Renal Drugs Advisory
Committee June 16, 2005
4
Open Public Hearing

• Debra Lee

Cardiovascular and Renal Drugs Advisory
Committee June 16, 2005
5
Open Public Hearing

• 5. Shomarka Omar Y. Keita, M.D., D.Phil.
• Medical Officer - Department of Human Services,
  District of Columbia
• Research Associate - Anthropology Department,
  Smithsonian Institution

Cardiovascular and Renal Drugs Advisory
Committee June 16, 2005
6
Open Public Hearing

• Jonathan Kahn, J.D., Ph.D.
• Assistant Professor
• Hamline University School of Law

Cardiovascular and Renal Drugs Advisory
Committee June 16, 2005
7
Open Public Hearing

• 7. Charles L. Curry, M.D., FACC, FACP
• President - International Society on
  Hypertension in Blacks

Cardiovascular and Renal Drugs Advisory
Committee June 16, 2005
8
Open Public Hearing

• 8. Basil Halliday, M.Sc.
• President CEO - BDH Clinical Research Services

Cardiovascular and Renal Drugs Advisory
Committee June 16, 2005
9
Open Public Hearing

• Charles N. Rotimi, Ph.D.
• National Human Genome Center
• Howard University

Cardiovascular and Renal Drugs Advisory
Committee June 16, 2005
10
Open Public Hearing

• Charmaine Royal, Ph.D.
• National Human Genome Center
• Howard University

Cardiovascular and Renal Drugs Advisory
Committee June 16, 2005
11
Open Public Hearing

• Olivia Carter-Pokras, Ph.D.
• Associate Professor University of Maryland,
  School of Medicine, Dept. of Epidemiology

Cardiovascular and Renal Drugs Advisory
Committee June 16, 2005
12
Open Public Hearing

• Lucille C. Norville Perez, MD
• National Health Director - National Association
• for the Advancement of Colored People

Cardiovascular and Renal Drugs Advisory
Committee June 16, 2005
13
Open Public Hearing

• 13. Dianna Wells

Cardiovascular and Renal Drugs Advisory
Committee June 16, 2005